Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
AK Medical Holdings Ltd. ( (HK:1789) ) just unveiled an update.
AK Medical reported revenue of RMB1.48 billion for 2025, up 10.1% year on year, driven by strong demand for its surgical products amid accelerated import substitution under China’s volume-based procurement policy. The rapid rise in surgeries and broader hospital coverage, supported by its digital orthopedics whole-process solutions, helped boost both product sales and uptake of customized digital offerings.
Net profit rose 23.8% to RMB339.1 million, reflecting not only topline growth but also an improved gross margin, aided by a higher contribution from overseas markets and digital orthopedics customized products and services. The board proposed a final dividend of HK$11.8 cents per share, signalling confidence in the Group’s profitability and providing a direct return to shareholders alongside its continued expansion in core and overseas markets.
The most recent analyst rating on (HK:1789) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on AK Medical Holdings Ltd. stock, see the HK:1789 Stock Forecast page.
More about AK Medical Holdings Ltd.
AK Medical Holdings Ltd. is a Cayman Islands-incorporated medical device company focused on orthopedic implants and digital orthopedics solutions. The Group provides surgical products and whole-process digital orthopedics services, with growing market coverage in hospitals in China and an expanding overseas footprint.
Average Trading Volume: 4,177,762
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.41B
See more data about 1789 stock on TipRanks’ Stock Analysis page.